Skip to main content
Premium Trial:

Request an Annual Quote

IBM and Spotfire Announce Alliance, Sign Aventis as First Client for Combined Offering

NEW YORK, June 25 - IBM and Spotfire said Monday they would work together to combine Spotfire's software with IBM's back-end information management, data integration, and computing infrastructure. 

The companies also said that Aventis would be the first customer to use this combination of Spotfire's DecisionSite analysis platform and IBM's DiscoveryLink integration middleware. 

Financial terms for the partnerships were not disclosed.

Under the IBM/Spotfire alliance, Spotfire will optimize its current and future applications for IBM platforms and middleware, including the DB2 database and DiscoveryLink.

Aventis will use DiscoveryLink to manage and integrate data from multiple biological and chemical databases and will use DecisionSite to allow researchers to query those databases and identify new drug targets. The company said it expects this combination of techniques to reduce its drug innovation and approval from 10-15 years to six to nine years.

Spotfire also has partnerships to integrate DecisionSite with products from Micromass and Celera, while IBM has partnerships to integrate DiscoveryLink with products from Micromass, LabBook, and NetGenics.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.